| Year |
Citation |
Score |
| 2016 |
Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. Plos One. 11: e0152243. PMID 26998759 DOI: 10.1371/journal.pone.0152243 |
0.825 |
|
| 2015 |
Liang M, Adisetiyo H, Liu X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. Plos One. 10: e0131232. PMID 26196517 DOI: 10.1371/Journal.Pone.0131232 |
0.853 |
|
| 2015 |
Xu S, Adisetiyo H, Tamura S, Grande F, Garofalo A, Roy-Burman P, Neamati N. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer. British Journal of Cancer. 113: 242-51. PMID 26103574 DOI: 10.1038/Bjc.2015.228 |
0.84 |
|
| 2015 |
Patel N, Itakura T, Jeong S, Liao CP, Roy-Burman P, Zandi E, Groshen S, Pinski J, Coetzee GA, Gross ME, Fini ME. Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression. Plos One. 10: e0117758. PMID 25693195 DOI: 10.1371/Journal.Pone.0117758 |
0.782 |
|
| 2015 |
Patel N, Itakura T, Jeong S, Liao C, Roy-Burman P, Zandi E, Groshen S, Pinski J, Coetzee GA, Gross ME, Fini ME. GPR158 subcellular localization in PCa cell lines and PHPECs. Plos One. DOI: 10.1371/Journal.Pone.0117758.G006 |
0.619 |
|
| 2014 |
Adisetiyo H, Liang M, Liao CP, Jeong JH, Cohen MB, Roy-Burman P, Frenkel B. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. Journal of Cellular Physiology. 229: 1170-6. PMID 24752784 DOI: 10.1002/Jcp.24546 |
0.858 |
|
| 2014 |
Geary LA, Nash KA, Adisetiyo H, Liang M, Liao CP, Jeong JH, Zandi E, Roy-Burman P. CAF-secreted annexin A1 induces prostate cancer cells to gain stem cell-like features. Molecular Cancer Research : McR. 12: 607-21. PMID 24464914 DOI: 10.1158/1541-7786.Mcr-13-0469 |
0.856 |
|
| 2013 |
Pham LK, Liang M, Adisetiyo HA, Liao CP, Cohen MB, Tahara SM, Frenkel B, Kasahara N, Roy-Burman P. Contextual effect of repression of bone morphogenetic protein activity in prostate cancer. Endocrine-Related Cancer. 20: 861-74. PMID 24042462 DOI: 10.1530/Erc-13-0100 |
0.835 |
|
| 2013 |
Adisetiyo H, Liang M, Liao CP, Aycock-Williams A, Cohen MB, Xu S, Neamati N, Conway EM, Cheng CY, Nikitin AY, Roy-Burman P. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. Plos One. 8: e69484. PMID 23936028 DOI: 10.1371/Journal.Pone.0069484 |
0.857 |
|
| 2013 |
Wu X, Gong S, Roy-Burman P, Lee P, Culig Z. Current mouse and cell models in prostate cancer research. Endocrine-Related Cancer. 20: R155-70. PMID 23580590 DOI: 10.1530/ERC-12-0285 |
0.568 |
|
| 2013 |
Liang M, Adisetiyo HA, Li X, Liu R, Gill PS, Roy-Burman P. Abstract 4087: Androgen receptor splice variants in mouse prostate cancer cell lines: altered distribution in lines derived from castration-resistant tumors relative to those primary tumors. Cancer Research. 73: 4087-4087. DOI: 10.1158/1538-7445.Am2013-4087 |
0.859 |
|
| 2012 |
Goel HL, Chang C, Pursell B, Leav I, Lyle S, Xi HS, Hsieh CC, Adisetiyo H, Roy-Burman P, Coleman IM, Nelson PS, Vessella RL, Davis RJ, Plymate SR, Mercurio AM. VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer. Cancer Discovery. 2: 906-21. PMID 22777769 DOI: 10.1158/2159-8290.Cd-12-0085 |
0.802 |
|
| 2012 |
Garlick DS, Li J, Sansoucy B, Wang T, Griffith L, Fitzgerald T, Butterfield J, Charbonneau B, Violette SM, Weinreb PH, Ratliff TL, Liao CP, Roy-Burman P, Vietri M, Lian JB, et al. α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma. American Journal of Translational Research. 4: 165-74. PMID 22611469 |
0.759 |
|
| 2012 |
Mao GE, Harris DM, Moro A, Heber D, Roy-Burman P, Zhang ZF, Rao J. A joint effect of new Western diet and retinoid X receptor α prostate-specific knockout with development of high-grade prostatic intraepithelial neoplasia in mice--a preliminary study. The Prostate. 72: 1052-9. PMID 22314496 DOI: 10.1002/Pros.22496 |
0.556 |
|
| 2012 |
Ting MC, Liao CP, Yan C, Jia L, Groshen S, Frenkel B, Roy-Burman P, Coetzee GA, Maxson R. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice. Disease Models & Mechanisms. 5: 366-74. PMID 22279083 DOI: 10.1242/Dmm.008458 |
0.784 |
|
| 2012 |
Geary L, Adisetiyo H, Liang M, Jeong H, Zandi E, Roy-Burman P. Abstract 1476: Prostate cancer-associated fibroblasts secrete Annexin A1 that facilitates both generation of cancer stem cell-like cells (CSCs) from prostatic malignant epithelial cells and self-renewal/differentiation of CSCs Cancer Research. 72: 1476-1476. DOI: 10.1158/1538-7445.Am2012-1476 |
0.837 |
|
| 2012 |
Garlick DS, Li J, Sansoucy B, Wang T, Griffith L, FitzGerald TJ, Butterfield J, Charbonneau B, Violette SM, Weinreb PH, Ratliff TL, Liao CP, Roy-Burman P, Vietri M, Lian JB, et al. α vβ 6 integrin expression is induced in the POET and Pten pc-/- mouse models of prostatic inflammation and prostatic adenocarcinoma American Journal of Translational Research. 4: 165-174. |
0.55 |
|
| 2011 |
Lim M, Chuong CM, Roy-Burman P. PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures. Hormones & Cancer. 2: 298-309. PMID 21948155 DOI: 10.1007/S12672-011-0084-4 |
0.689 |
|
| 2011 |
Jeong JH, Bhatia A, Toth Z, Oh S, Inn KS, Liao CP, Roy-Burman P, Melamed J, Coetzee GA, Jung JU. TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth. Plos One. 6: e16205. PMID 21267413 DOI: 10.1371/Journal.Pone.0016205 |
0.79 |
|
| 2011 |
Adisetiyo HA, Liang M, Liao C, Aycock-Williams A, Cohen MB, Conway EM, Roy-Burman P. Abstract LB-51: Pten null prostate tumorigenesis and prostate stem cell activity are inhibited by targeted knockout of the Survivin gene Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-51 |
0.869 |
|
| 2011 |
Geary L, Zandi E, Roy-Burman P. Abstract LB-301: Potential role of prostate cancer-associated fibroblasts in inducing stem cell-like properties to the malignant epithelial cells of the prostate Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-301 |
0.62 |
|
| 2010 |
Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancer stem cells and microenvironment in prostate cancer progression. Hormones & Cancer. 1: 297-305. PMID 21761361 DOI: 10.1007/S12672-010-0051-5 |
0.867 |
|
| 2010 |
Liao CP, Adisetiyo H, Liang M, Roy-Burman P. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Research. 70: 7294-303. PMID 20807814 DOI: 10.1158/0008-5472.Can-09-3982 |
0.865 |
|
| 2010 |
Liao CP, Liang M, Cohen MB, Flesken-Nikitin A, Jeong JH, Nikitin AY, Roy-Burman P. Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. Hormones & Cancer. 1: 44-54. PMID 20631921 DOI: 10.1007/S12672-009-0005-Y |
0.795 |
|
| 2010 |
Lim M, Zhong C, Yang S, Bell AM, Cohen MB, Roy-Burman P. Runx2 regulates survivin expression in prostate cancer cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 222-33. PMID 19949374 DOI: 10.1038/Labinvest.2009.128 |
0.829 |
|
| 2010 |
Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B, Yi Y, Magnuson MA, Roy-Burman P, Matusik RJ, Shappell SB, Hayward SW. Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy Cell Death and Differentiation. 17: 469-481. PMID 19834493 DOI: 10.1038/Cdd.2009.148 |
0.504 |
|
| 2009 |
Fujino Y, Liao CP, Zhao YS, Pan J, Mathes LE, Hayes KA, Ohno K, Tsujimoto H, Roy-Burman P. Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma. Virology. 386: 16-22. PMID 19203775 DOI: 10.1016/J.Virol.2009.01.021 |
0.694 |
|
| 2009 |
Haga K, Tomioka A, Liao CP, Kimura T, Matsumoto H, Ohno I, Hermann K, Logg CR, Jiao J, Tanaka M, Hirao Y, Wu H, Kruse CA, Roy-Burman P, Kasahara N. PTEN knockout prostate cancer as a model for experimental immunotherapy. The Journal of Urology. 181: 354-62. PMID 19010487 DOI: 10.1016/J.Juro.2008.08.124 |
0.756 |
|
| 2009 |
Yu X, Wang Y, Jiang M, Bierie B, Roy-Burman P, Shen MM, Taketo MM, Wills M, Matusik RJ. Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration. The Prostate. 69: 249-62. PMID 18991257 DOI: 10.1002/Pros.20877 |
0.501 |
|
| 2008 |
Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P, Lee AS. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proceedings of the National Academy of Sciences of the United States of America. 105: 19444-9. PMID 19033462 DOI: 10.1073/Pnas.0807691105 |
0.793 |
|
| 2008 |
Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, Roy-Burman P. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Research. 68: 198-205. PMID 18172312 DOI: 10.1158/0008-5472.Can-07-5074 |
0.804 |
|
| 2008 |
Haga K, Tomioka A, Kimura T, Liao C, Matsumoto H, Ohno I, Logg CR, Hermann KJ, Tanaka M, Uemura H, Hirao Y, Roy-Burman P, Kasahara N. SUICIDE GENE THERAPY USING REPLICATION-COMPETENT RETROVIRUS (RCR) COMBINED WITH TUMOR-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTLs) FOR PTEN KNOCK-OUT SPONTANEOUS PROSTATE CANCER MODEL Journal of Urology. 179: 41-42. DOI: 10.1016/S0022-5347(08)60126-3 |
0.72 |
|
| 2007 |
Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Research. 67: 7525-33. PMID 17671224 DOI: 10.1158/0008-5472.Can-07-0668 |
0.806 |
|
| 2007 |
Nikitin AY, Matoso A, Roy-Burman P. Prostate stem cells and cancer Histology and Histopathology. 22: 1043-1049. PMID 17523082 DOI: 10.14670/Hh-22.1043 |
0.534 |
|
| 2007 |
Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO. Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Research. 67: 2490-6. PMID 17363566 DOI: 10.1158/0008-5472.Can-06-3028 |
0.61 |
|
| 2006 |
Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P, Nikitin AY. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Research. 66: 7889-98. PMID 16912162 DOI: 10.1158/0008-5472.Can-06-0486 |
0.627 |
|
| 2006 |
Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, Altieri DC, Roy-Burman P. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Cancer Research. 66: 4285-90. PMID 16618753 DOI: 10.1158/0008-5472.Can-05-4456 |
0.758 |
|
| 2006 |
Zhong C, Saribekyan G, Liao CP, Cohen MB, Roy-Burman P. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Research. 66: 2188-94. PMID 16489020 DOI: 10.1158/0008-5472.Can-05-3440 |
0.804 |
|
| 2006 |
Khodavirdi AC, Song Z, Yang S, Zhong C, Wang S, Wu H, Pritchard C, Nelson PS, Roy-Burman P. Increased expression of osteopontin contributes to the progression of prostate cancer. Cancer Research. 66: 883-8. PMID 16424021 DOI: 10.1158/0008-5472.Can-05-2816 |
0.862 |
|
| 2005 |
Pan J, Al-Dubaib M, Liao CP, Fujino Y, Hinton DR, Hayes KA, Mathes LE, Roy-Burman P. In vivo expression of GFP transgene delivered via a replicating feline leukemia virus. Veterinary Microbiology. 110: 181-95. PMID 16143471 DOI: 10.1016/J.Vetmic.2005.07.015 |
0.701 |
|
| 2005 |
Roy-Burman P, Tindall DJ, Robins DM, Greenberg NM, Hendrix MJ, Mohla S, Getzenberg RH, Isaacs JT, Pienta KJ. Androgens and prostate cancer: are the descriptors valid? Cancer Biology & Therapy. 4: 4-5. PMID 16052746 DOI: 10.4161/Cbt.4.1.1563 |
0.595 |
|
| 2005 |
Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Research. 65: 5769-77. PMID 15994952 DOI: 10.1158/0008-5472.Can-05-0289 |
0.812 |
|
| 2005 |
Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, ... Roy-Burman P, et al. EphB4 expression and biological significance in prostate cancer. Cancer Research. 65: 4623-32. PMID 15930280 DOI: 10.1158/0008-5472.Can-04-2667 |
0.777 |
|
| 2005 |
Wu H, Khodavirdi A, Roy-Burman P. Capturing signal anomalies of human prostate cancer into mouse models Prostate Cancer: Basic Mechanisms and Therapeutic Approaches. 393-421. DOI: 10.1142/9789812569202_0017 |
0.831 |
|
| 2004 |
Roy-Burman P, Wu H, Powell WC, Hagenkord J, Cohen MB. Genetically defined mouse models that mimic natural aspects of human prostate cancer development Endocrine-Related Cancer. 11: 225-254. PMID 15163300 DOI: 10.1677/Erc.0.0110225 |
0.637 |
|
| 2003 |
Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP. Pten dose dictates cancer progression in the prostate. Plos Biology. 1: E59. PMID 14691534 DOI: 10.1371/Journal.Pbio.0000059 |
0.598 |
|
| 2003 |
Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 4: 209-21. PMID 14522255 DOI: 10.1016/S1535-6108(03)00215-0 |
0.66 |
|
| 2003 |
Zhong C, Yang S, Huang J, Cohen MB, Roy-Burman P. Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. Cancer Biology & Therapy. 2: 179-84. PMID 12750559 DOI: 10.4161/Cbt.2.2.281 |
0.85 |
|
| 2003 |
Pan J, Zhong C, Chang Z, Roy-Burman P. A potential therapeutic strategy to combat leukemia virus infection. Cancer Biology & Therapy. 2: 92-9. PMID 12673127 DOI: 10.4161/Cbt.236 |
0.655 |
|
| 2003 |
Powell WC, Cardiff RD, Cohen MB, Miller GJ, Roy-Burman P. Mouse strains for prostate tumorigenesis based on genes altered in human prostate cancer Current Drug Targets. 4: 263-279. PMID 12643476 DOI: 10.2174/1389450033491145 |
0.606 |
|
| 2002 |
Song Z, Wu X, Powell WC, Cardiff RD, Cohen MB, Tin RT, Matusik RJ, Miller GJ, Roy-Burman P. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Research. 62: 5096-105. PMID 12208767 |
0.693 |
|
| 2002 |
Huang J, Powell WC, Khodavirdi AC, Wu J, Makita T, Cardiff RD, Cohen MB, Sucov HM, Roy-Burman P. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Research. 62: 4812-9. PMID 12183441 |
0.857 |
|
| 2001 |
Chang Z, Pan J, Logg C, Kasahara N, Roy-Burman P. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A. Journal of Virology. 75: 8837-41. PMID 11507228 DOI: 10.1128/Jvi.75.18.8837-8841.2001 |
0.59 |
|
| 2001 |
Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ, Sangiorgi FO, Maxson RE, Sucov HM, Roy-Burman P. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mechanisms of Development. 101: 61-9. PMID 11231059 DOI: 10.1016/S0925-4773(00)00551-7 |
0.71 |
|
| 2000 |
Song Z, Powell WC, Kasahara N, van Bokhoven A, Miller GJ, Roy-Burman P. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells. Cancer Research. 60: 6730-6. PMID 11118059 |
0.696 |
|
| 2000 |
Ghosh SK, Roy-Burman P, Faller DV. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression. Journal of Virology. 74: 9742-8. PMID 11000248 DOI: 10.1128/Jvi.74.20.9742-9748.2000 |
0.344 |
|
| 2000 |
Phipps AJ, Chen H, Hayes KA, Roy-Burman P, Mathes LE. Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A. Journal of Virology. 74: 5796-801. PMID 10846058 DOI: 10.1128/Jvi.74.13.5796-5801.2000 |
0.336 |
|
| 2000 |
Hoang AT, Huang J, Rudra-Ganguly N, Zheng J, Powell WC, Rabindran SK, Wu C, Roy-Burman P. A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. The American Journal of Pathology. 156: 857-64. PMID 10702402 DOI: 10.1016/S0002-9440(10)64954-1 |
0.709 |
|
| 2000 |
Shi Y, Roy-Burman P. A novel truncated env gene isolated from a feline leukemia virus-induced thymic lymphosarcoma Journal of Virology. 74: 1451-1456. PMID 10627556 DOI: 10.1128/Jvi.74.3.1451-1456.2000 |
0.362 |
|
| 1999 |
Zheng J, Rudra-Ganguly N, Powell WC, Roy-Burman P. Suppression of prostate carcinoma cell invasion by expression of antisense L-plastin gene American Journal of Pathology. 155: 115-122. PMID 10393844 DOI: 10.1016/S0002-9440(10)65106-1 |
0.545 |
|
| 1999 |
Bechtel MK, Hayes KA, Mathes LE, Pandey R, Stromberg PC, Roy-Burman P. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus. Veterinary Pathology. 36: 91-9. PMID 10098636 DOI: 10.1354/Vp.36-2-91 |
0.309 |
|
| 1998 |
Rudra-Ganguly N, Ghosh AK, Roy-Burman P. Retrovirus receptor PiT-1 of the Felis catus Biochimica Et Biophysica Acta - Gene Structure and Expression. 1443: 407-413. PMID 9878855 DOI: 10.1016/S0167-4781(98)00241-3 |
0.311 |
|
| 1998 |
Chen H, Bechtel MK, Shi Y, Phipps A, Mathes LE, Hayes KA, Roy-Burman P. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA). Journal of Virology. 72: 7048-56. PMID 9696797 DOI: 10.1128/Jvi.72.9.7048-7056.1998 |
0.307 |
|
| 1998 |
Bechtel MK, Mathes LE, Hayes KA, Phipps AJ, Roy-Burman P. In vivo evolution and selection of recombinant feline leukemia virus species. Virus Research. 54: 71-86. PMID 9660073 DOI: 10.1016/S0168-1702(98)00015-X |
0.308 |
|
| 1998 |
Rudra-Ganguly N, Zheng J, Hoang AT, Roy-Burman P. Downregulation of human FGF8 activity by antisense constructs in murine fibroblastic and human prostatic carcinoma cell systems Oncogene. 16: 1487-1492. PMID 9525747 DOI: 10.1038/Sj.Onc.1201652 |
0.55 |
|
| 1998 |
Roy-Burman P, Zheng J, Miller GJ. Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis? Molecular Medicine Today. 3: 476-82. PMID 9430782 DOI: 10.1016/S1357-4310(97)01126-X |
0.584 |
|
| 1997 |
Salem CE, Tomasic NA, Elmajian DA, Esrig D, Nichols PW, Taylor CR, Skinner DG, Roy-Burman P, Lieskovsky G, Cote RJ. p53 protein and gene alterations in pathological stage C prostate carcinoma. The Journal of Urology. 158: 510-4. PMID 9224335 DOI: 10.1016/S0022-5347(01)64520-8 |
0.595 |
|
| 1997 |
Zheng J, Rudra-Ganguly N, Miller GJ, Moffatt KA, Cote RJ, Roy-Burman P. Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues American Journal of Pathology. 150: 2009-2018. PMID 9176394 |
0.531 |
|
| 1997 |
Zheng J, Miller GJ, Roy-Burman P. Hcular heterogeneityostate cancer: Canmutation unravelrigenesis? Molecular Medicine Today. 3: 476-482. |
0.44 |
|
| 1996 |
Ghosh AK, Shankar DB, Shackleford GM, Wu K, T'Ang A, Miller GJ, Zheng J, Roy-Burman P. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms Cell Growth and Differentiation. 7: 1425-1434. PMID 8891346 |
0.364 |
|
| 1995 |
Roy-Burman P. Endogenous env elements: Partners in generation of pathogenic feline leukemia viruses Virus Genes. 11: 147-161. PMID 8828142 DOI: 10.1007/Bf01728655 |
0.336 |
|
| 1993 |
Sheets RL, Pandey R, Jen WC, Roy-Burman P. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas Journal of Virology. 67: 3118-3125. PMID 8388492 DOI: 10.1128/Jvi.67.6.3118-3125.1993 |
0.305 |
|
| 1992 |
Sheets RL, Pandey R, Klement V, Grant CK, Roy-burman P. Biologically selected recombinants between Feline Leukemia Virus (FeLV) subgroup a and an endogenous FeLV element Virology. 190: 849-855. PMID 1381539 DOI: 10.1016/0042-6822(92)90924-E |
0.301 |
|
| 1991 |
Pandey R, Ghosh AK, Kumar DV, Bachman BA, Shibata D, Roy-Burman P. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses Journal of Virology. 65: 6495-6508. PMID 1658356 DOI: 10.1128/Jvi.65.12.6495-6508.1991 |
0.34 |
|
| 1983 |
Roy-Burman P, Devi BG, Parker JW. Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias. International Journal of Cancer. 32: 185-91. PMID 6603429 DOI: 10.1002/Ijc.2910320208 |
0.332 |
|
| 1983 |
Busch MP, Devi BG, Soe LH, Perbal B, Baluda MA, Roy-Burman P. Characterization of the expression of cellular retrovirus genes and oncogenesis in feline cells Hematological Oncology. 1: 61-75. PMID 6329934 DOI: 10.1002/Hon.2900010108 |
0.312 |
|
| 1979 |
Yang YH, Rhim JS, Rasheed S, Klement V, Roy-Burman P. Reversion of Kirsten sarcoma virus transformed human cells: Elimination of the sarcoma virus nucleotide sequences Journal of General Virology. 43: 447-451. PMID 225428 DOI: 10.1099/0022-1317-43-2-447 |
0.322 |
|
| 1978 |
Klement V, Dougherty MF, Roy-Burman P, Pal BK, Shimizu CS, Rongey RW, Nelson-Rees W, Huebner RJ. Endogenous type C RNA virus of mink (Mustela vison). Virology. 85: 296-306. PMID 206010 DOI: 10.1016/0042-6822(78)90433-6 |
0.316 |
|
| 1977 |
Niman HL, Gardner MB, Stephenson JR, Roy-Burman P. Endogenous RD-114 virus genome expression in malignant tissues of domestic cats. Journal of Virology. 23: 578-86. PMID 197261 DOI: 10.1128/Jvi.23.3.578-586.1977 |
0.328 |
|
| 1977 |
Niman HL, Stephenson JR, Gardner MB, Roy-Burman P. RD-114 and feline leukaemia virus genome expression in natural lymphomas of domestic cats. Nature. 266: 357-60. PMID 193031 DOI: 10.1038/266357A0 |
0.307 |
|
| 1975 |
Roy-Burman P, Pal BK, Kaplan MB, Wright M, Gardner MB. Biochemical properties of wild mouse oncornaviruses with lymphomagenic and neurotropic activities. Bibliotheca Haematologica. 627-37. PMID 169831 DOI: 10.1159/000397584 |
0.302 |
|
| Show low-probability matches. |